OMERS Ventures Backs Fusion Diagnostics Firm Daedal Systems

OMERS Ventures has invested in Daedal Systems, a company building diagnostics technology for nuclear fusion, Benefits and Pensions Monitor reports.

The deal marks the latest move by the venture capital arm of the Ontario Municipal Employees Retirement System into deep-tech energy infrastructure. The exact size of the investment and Daedal Systems' valuation were not disclosed in the report.

Daedal Systems operates in fusion diagnostics — the instruments and measurement systems that determine what is happening inside a fusion plasma. In a fusion reactor, no physical probe can survive contact with plasma that runs hotter than the sun's core. Operators instead rely on diagnostic tools that read radiation, magnetic behavior and particle flows from outside the reaction chamber. Those measurements decide whether a plasma is stable, whether confinement is holding and whether a shot at net energy gain is working.

That makes diagnostics a critical layer of the fusion supply chain. Commercial fusion developers have raised billions of dollars in recent years, and every one of their machines depends on measurement systems to validate performance. Companies in this niche sell not to one reactor builder but, in principle, to the entire field.

For OMERS Ventures, the investment fits a broader pattern among pension-backed investors. Funds managing retirement money have steadily increased allocations to private markets, including venture capital, in search of returns that public equities no longer reliably deliver. Infrastructure-adjacent technology — energy systems among them — carries particular appeal for long-horizon investors, because the asset class matches liabilities that stretch decades into the future.

OMERS, one of Canada's largest pension plans, has built a substantial in-house capital markets operation and runs OMERS Ventures as its early-stage and growth-equity arm. A fusion diagnostics bet sits at the far end of the risk spectrum from the plan's core real estate and infrastructure holdings. It is a venture position: most fusion ventures will fail, and the few that succeed could return multiples of their cost basis.

The reported deal does not disclose which round Daedal Systems raised, who else participated, or what the company plans to do with the capital. The Benefits and Pensions Monitor report identifies only the investor, the target and the target's field.

The investment nonetheless signals where institutional venture money is looking. Fusion has moved from government laboratories toward private companies backed by named investors writing nine- and ten-figure checks. Supply-chain firms — those making magnets, fuel systems, materials and, in Daedal Systems' case, diagnostics — attract capital on the thesis that they capture value regardless of which reactor design ultimately wins.

For OMERS Ventures, the question now is execution: whether Daedal Systems' measurement tools land contracts with the fusion developers spending the industry's capital, and whether a diagnostics niche can grow into a business large enough to matter inside a pension plan's portfolio.